Annual EBITDA
-$110.84 M
-$24.92 M-29.00%
December 31, 2023
Summary
- As of February 7, 2025, AFMD annual EBITDA is -$110.84 million, with the most recent change of -$24.92 million (-29.00%) on December 31, 2023.
- During the last 3 years, AFMD annual EBITDA has fallen by -$64.98 million (-141.70%).
- AFMD annual EBITDA is now -2040.53% below its all-time high of $5.71 million, reached on December 31, 2014.
Performance
AFMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$15.89 M
-$57.40 K-0.36%
September 1, 2024
Summary
- As of February 7, 2025, AFMD quarterly EBITDA is -$15.89 million, with the most recent change of -$57.40 thousand (-0.36%) on September 1, 2024.
- Over the past year, AFMD quarterly EBITDA has increased by +$4.91 million (+23.63%).
- AFMD quarterly EBITDA is now -235.37% below its all-time high of $11.74 million, reached on September 30, 2014.
Performance
AFMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$70.68 M
+$9.39 M+11.72%
September 1, 2024
Summary
- As of February 7, 2025, AFMD TTM EBITDA is -$70.68 million, with the most recent change of +$9.39 million (+11.72%) on September 1, 2024.
- Over the past year, AFMD TTM EBITDA has increased by +$40.14 million (+36.22%).
- AFMD TTM EBITDA is now -610.75% below its all-time high of $13.84 million, reached on March 31, 2015.
Performance
AFMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AFMD EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -29.0% | +23.6% | +36.2% |
3 y3 years | -141.7% | +18.1% | -24.7% |
5 y5 years | -415.0% | +18.1% | -24.7% |
AFMD EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -68.9% | at low | -0.4% | +52.6% | -8.3% | +42.0% |
5 y | 5-year | -219.7% | at low | -825.2% | +52.6% | -105.2% | +42.0% |
alltime | all time | -2040.5% | at low | -235.4% | +52.6% | -610.8% | +42.0% |
Affimed NV EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$15.89 M(+0.4%) | -$70.68 M(-11.7%) |
Jun 2024 | - | -$15.83 M(-12.8%) | -$80.07 M(-16.1%) |
Mar 2024 | - | -$18.16 M(-12.7%) | -$95.47 M(-13.9%) |
Dec 2023 | -$110.84 M(+29.0%) | -$20.80 M(-17.7%) | -$110.83 M(-9.1%) |
Sep 2023 | - | -$25.27 M(-19.1%) | -$121.87 M(+8.4%) |
Jun 2023 | - | -$31.23 M(-6.9%) | -$112.43 M(+11.2%) |
Mar 2023 | - | -$33.52 M(+5.3%) | -$101.10 M(+18.3%) |
Dec 2022 | -$85.92 M(+30.9%) | -$31.85 M(+101.1%) | -$85.45 M(+7.3%) |
Sep 2022 | - | -$15.83 M(-20.4%) | -$79.66 M(-4.3%) |
Jun 2022 | - | -$19.89 M(+11.3%) | -$83.22 M(-2.5%) |
Mar 2022 | - | -$17.88 M(-31.4%) | -$85.32 M(+30.8%) |
Dec 2021 | -$65.64 M(+43.1%) | -$26.05 M(+34.3%) | -$65.25 M(+15.1%) |
Sep 2021 | - | -$19.39 M(-11.8%) | -$56.67 M(+29.1%) |
Jun 2021 | - | -$22.00 M(-1104.1%) | -$43.89 M(+25.4%) |
Mar 2021 | - | $2.19 M(-112.5%) | -$35.00 M(-23.8%) |
Dec 2020 | -$45.86 M(+32.3%) | -$17.48 M(+164.4%) | -$45.96 M(+8.1%) |
Sep 2020 | - | -$6.61 M(-49.6%) | -$42.50 M(-10.8%) |
Jun 2020 | - | -$13.11 M(+49.5%) | -$47.62 M(+4.1%) |
Mar 2020 | - | -$8.77 M(-37.5%) | -$45.74 M(+32.8%) |
Dec 2019 | -$34.67 M(+61.1%) | -$14.02 M(+19.5%) | -$34.44 M(+240.6%) |
Sep 2019 | - | -$11.73 M(+4.5%) | -$10.11 M(-15.8%) |
Jun 2019 | - | -$11.22 M(-544.4%) | -$12.00 M(+20.5%) |
Mar 2019 | - | $2.53 M(-75.5%) | -$9.97 M(-55.0%) |
Dec 2018 | -$21.52 M | $10.31 M(-175.7%) | -$22.15 M(-44.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2018 | - | -$13.62 M(+48.3%) | -$39.58 M(+12.8%) |
Jun 2018 | - | -$9.18 M(-4.9%) | -$35.09 M(+1.5%) |
Mar 2018 | - | -$9.66 M(+35.5%) | -$34.58 M(+5.0%) |
Dec 2017 | -$33.07 M(-3.9%) | -$7.13 M(-22.0%) | -$32.92 M(+4.8%) |
Sep 2017 | - | -$9.13 M(+5.3%) | -$31.42 M(-6.0%) |
Jun 2017 | - | -$8.67 M(+8.5%) | -$33.43 M(-0.2%) |
Mar 2017 | - | -$7.99 M(+42.0%) | -$33.51 M(-2.9%) |
Dec 2016 | -$34.42 M(+61.6%) | -$5.63 M(-49.5%) | -$34.52 M(-2.7%) |
Sep 2016 | - | -$11.14 M(+27.3%) | -$35.49 M(+10.4%) |
Jun 2016 | - | -$8.75 M(-2.8%) | -$32.14 M(+11.5%) |
Mar 2016 | - | -$9.00 M(+36.4%) | -$28.83 M(+35.8%) |
Dec 2015 | -$21.31 M(-473.0%) | -$6.60 M(-15.2%) | -$21.22 M(+0.8%) |
Sep 2015 | - | -$7.79 M(+43.1%) | -$21.05 M(+1278.0%) |
Jun 2015 | - | -$5.44 M(+290.3%) | -$1.53 M(-111.0%) |
Mar 2015 | - | -$1.39 M(-78.3%) | $13.84 M(-420.4%) |
Dec 2014 | $5.71 M(-120.6%) | -$6.43 M(-154.8%) | -$4.32 M(-808.8%) |
Sep 2014 | - | $11.74 M(+18.3%) | $609.30 K(-102.5%) |
Jun 2014 | - | $9.92 M(-150.8%) | -$24.58 M(-40.9%) |
Mar 2014 | - | -$19.55 M(+1204.6%) | -$41.59 M(+62.9%) |
Dec 2013 | -$27.67 M(+115.5%) | -$1.50 M(-88.9%) | -$25.53 M(+6.2%) |
Sep 2013 | - | -$13.45 M(+89.7%) | -$24.03 M(+127.1%) |
Jun 2013 | - | -$7.09 M(+102.9%) | -$10.58 M(+202.9%) |
Mar 2013 | - | -$3.49 M | -$3.49 M |
Dec 2012 | -$12.84 M | - | - |
FAQ
- What is Affimed NV annual EBITDA?
- What is the all time high annual EBITDA for Affimed NV?
- What is Affimed NV annual EBITDA year-on-year change?
- What is Affimed NV quarterly EBITDA?
- What is the all time high quarterly EBITDA for Affimed NV?
- What is Affimed NV quarterly EBITDA year-on-year change?
- What is Affimed NV TTM EBITDA?
- What is the all time high TTM EBITDA for Affimed NV?
- What is Affimed NV TTM EBITDA year-on-year change?
What is Affimed NV annual EBITDA?
The current annual EBITDA of AFMD is -$110.84 M
What is the all time high annual EBITDA for Affimed NV?
Affimed NV all-time high annual EBITDA is $5.71 M
What is Affimed NV annual EBITDA year-on-year change?
Over the past year, AFMD annual EBITDA has changed by -$24.92 M (-29.00%)
What is Affimed NV quarterly EBITDA?
The current quarterly EBITDA of AFMD is -$15.89 M
What is the all time high quarterly EBITDA for Affimed NV?
Affimed NV all-time high quarterly EBITDA is $11.74 M
What is Affimed NV quarterly EBITDA year-on-year change?
Over the past year, AFMD quarterly EBITDA has changed by +$4.91 M (+23.63%)
What is Affimed NV TTM EBITDA?
The current TTM EBITDA of AFMD is -$70.68 M
What is the all time high TTM EBITDA for Affimed NV?
Affimed NV all-time high TTM EBITDA is $13.84 M
What is Affimed NV TTM EBITDA year-on-year change?
Over the past year, AFMD TTM EBITDA has changed by +$40.14 M (+36.22%)